Steris (NYSE: STE) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.

GUIDANCE:

Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $7.91.

For earnings history and earnings-related data on Steris (STE) click here.